31 results
8-K
EX-3.1
PCSA
Processa Pharmaceuticals Inc
21 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:29pm
to a reasonable stockholder’s understanding of the independence, or lack thereof, of such nominee. Any such update or supplement shall be delivered
8-K
EX-1.1
xytwwimasdmejg9xd1
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
424B4
22ovw07w
5 Oct 20
Prospectus supplement with pricing info
4:16pm
DEF 14A
fqjclxs
26 Apr 19
Definitive proxy
5:02pm
424B3
e3qalfj0l
9 Nov 18
Prospectus supplement
5:04pm